Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhagya Shree

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
FEBS Letters|January 18, 2023
Lipocalin 2 inhibits actin glutathionylation to promote invasion and migrationBhagya Shree Choudhary, Nazia Chaudhary, Manya Shah, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
PDK1 and YAP1/TEAD signaling drive acquired KRAS inhibitor resistance in KRAS-mutant non-small cell lung cancerAmrita Barua, Samrat T Kundu, Sofia G Garza, et al.
Cancer Cell International|February 19, 2025
EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKINazia Chaudhary, Bhagya Shree Choudhary, Anusha Shivashankar, et al.
Journal of Cell Science|May 13, 2025
LCN2 promotes focal adhesion formation and invasion by stimulating c-Src activationBhagya Shree Choudhary, Nazia Chaudhary, Bushra K Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2025
Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell CarcinomasNazia Chaudhary, Alessandro La Ferlita, Bhagya Shree Choudhary, et al.
International Journal of Cancer|June 19, 2021
Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancerNazia Chaudhary, Bhagya Shree Choudhary, Sanket Girish Shah, et al.
Redox Biology|December 20, 2024
Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancerEeshrita Jog, Ashwin Kumar Jainarayanan, Alessandro La Ferlita, et al.
Redox Biology|September 19, 2025
Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulationNazia Chaudhary, Dibita Mandal, Bhagya Shree Choudhary, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
FEBS Letters|January 18, 2023
Lipocalin 2 inhibits actin glutathionylation to promote invasion and migrationBhagya Shree Choudhary, Nazia Chaudhary, Manya Shah, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
PDK1 and YAP1/TEAD signaling drive acquired KRAS inhibitor resistance in KRAS-mutant non-small cell lung cancerAmrita Barua, Samrat T Kundu, Sofia G Garza, et al.
Cancer Cell International|February 19, 2025
EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKINazia Chaudhary, Bhagya Shree Choudhary, Anusha Shivashankar, et al.
Journal of Cell Science|May 13, 2025
LCN2 promotes focal adhesion formation and invasion by stimulating c-Src activationBhagya Shree Choudhary, Nazia Chaudhary, Bushra K Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2025
Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell CarcinomasNazia Chaudhary, Alessandro La Ferlita, Bhagya Shree Choudhary, et al.
International Journal of Cancer|June 19, 2021
Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancerNazia Chaudhary, Bhagya Shree Choudhary, Sanket Girish Shah, et al.
Redox Biology|December 20, 2024
Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancerEeshrita Jog, Ashwin Kumar Jainarayanan, Alessandro La Ferlita, et al.
Redox Biology|September 19, 2025
Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulationNazia Chaudhary, Dibita Mandal, Bhagya Shree Choudhary, et al.
Pageof 2